Skip to main content

Table 3 Between-group differences for DECTIN-1 Y238X genotype in joint-damage progression

From: Functional consequences of DECTIN-1early stop codon polymorphism Y238X in rheumatoid arthritis

Parameter

Estimate

SE

Pvalue

Intercept

3.32

0.32

< 0.0001

DECTIN-1 genotype

0.05

0.79

0.95

Intercept

1.07

0.58

0.065

DECTIN-1 genotype

-0.40

0.71

0.57

Joint damage at baseline

2.65

0.53

< 0.0001

Rheumatoid factor +

1.28

0.63

0.043

Average DAS28a

1.26

0.24

< 0.0001

  1. DAS28: Disease Activity Score using 28 joint counts. Results of the linear regression model with 262 RA patients. The upper model tests the difference in annual joint-damage progression rate between wild-type patients and patients heterozygous for the DECTIN-1 Y238X polymorphism, indicated by the estimate of DECTIN-1 genotype (P = 0.95). The lower model tests the same (P = 0.57), with addition of baseline joint damage, rheumatoid factor positivity, and the time-averaged DAS28 as confounders. aTime-averaged DAS28 was centered.